Romano Kathryn's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Feb 28, 2024
- Accession no.
- 0001801385-24-000007
- Filed
- Feb 28, 2024
- Trade date
- Feb 26-27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.11M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Romano KathrynCIK 0001801385 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $52.26 | +$261,300 | 17,556 | Direct | |
| Feb 26, 2024 | Common Stock | SSaleDisposed | −5,000 | $135.00F2 | −$675,000 | 12,556 | Direct | |
| Feb 26, 2024 | Common Stock | MOption exerciseAcquired | +3,087 | $52.26 | +$161,326.62 | 15,643 | Direct | |
| Feb 26, 2024 | Common Stock | SSaleDisposed | −3,087 | $140.00F2 | −$432,180 | 12,556 | Direct | |
| Feb 26, 2024 | Common Stock | FTax withholdingDisposed | −1,533 | $157.00F5 | −$240,681 | 11,023 | Direct | |
| Feb 27, 2024 | Common Stock | MOption exerciseAcquired | +1,913 | $52.26 | +$99,973.38 | 12,936 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 5,000 | Direct | |
| Feb 26, 2024 | Common Stock | MOption exerciseDisposed | −3,087 | $0.00 | $0 | 1,913 | Direct | |
| Feb 27, 2024 | Common Stock | MOption exerciseDisposed | −1,913 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades at the same sale price.
Referenced by the price of 2 transactions in Table I.
- F5
The closing price on February 26, 2024 of the Company's common stock on NASDAQ.
Referenced by the price of 1 transaction in Table I.